Barbara Tilley to Myocardial Infarction
This is a "connection" page, showing publications Barbara Tilley has written about Myocardial Infarction.
Connection Strength
0.203
-
Economic analysis of secondary trial data. Prog Cardiovasc Dis. 2012 Jan-Feb; 54(4):351-6.
Score: 0.066
-
Lower thrombolytic use for African Americans with myocardial infarction: an influence of clinical presentation? Am Heart J. 1999 Feb; 137(2):338-45.
Score: 0.027
-
Antiphospholipid Antibodies and Recurrent Thrombotic Events: Persistence and Portfolio. Cerebrovasc Dis. 2015; 40(5-6):293-300.
Score: 0.021
-
Prognostic significance of electrocardiographic persistent ST depression in patients with their first myocardial infarction in the placebo arm of the Beta-Blocker Heart Attack Trial. Am Heart J. 1993 Aug; 126(2):271-8.
Score: 0.018
-
Natural history of the first non-Q wave myocardial infarction in the placebo arm of the Beta-Blocker Heart Attack Trial. Am Heart J. 1991 Dec; 122(6):1548-53.
Score: 0.016
-
Effects of propranolol in non-Q-wave acute myocardial infarction in the beta blocker heart attack trial. Am J Cardiol. 1990 Jul 15; 66(2):129-33.
Score: 0.015
-
Effects of cigarette smoking and propranolol in survivors of acute myocardial infarction. Am J Cardiol. 1990 Feb 01; 65(5):271-6.
Score: 0.014
-
Risk identification at the time of admission to coronary care unit in patients with suspected myocardial infarction. Am Heart J. 1988 Nov; 116(5 Pt 1):1212-7.
Score: 0.013
-
Efficacy of propranolol therapy after acute myocardial infarction related to coronary arterial anatomy and left ventricular function. Am J Cardiol. 1987 Nov 01; 60(13):976-80.
Score: 0.012